
Minimally Invasive Glaucoma Surgeries (MIGS)
What is Glaucoma?
Glaucoma is a group of eye diseases that damage the optic nerve, often due to elevated pressure inside the eye. It's often called the 'silent thief of sight' because it can cause permanent vision loss without early warning signs, making early detection and treatment critical.
This is the most common type, affecting millions of Americans. It develops slowly when the eye's drainage system becomes less efficient over time, causing fluid to build up and pressure to increase. Most people don't notice symptoms until significant vision loss has already occurred.
This less common type happens when the drainage angle becomes completely blocked, causing a sudden, severe increase in eye pressure. Symptoms include intense eye pain, headaches, nausea, and blurred vision. This is a medical emergency that requires immediate treatment.
Some cases develop as a result of other eye conditions, injuries, medications like steroids, or medical problems such as diabetes. Understanding the underlying cause helps our ophthalmologists guide treatment decisions.
Major risk factors include age over 60, a family history of glaucoma, African American or Hispanic heritage, high nearsightedness, thin corneas, and systemic conditions like diabetes and high blood pressure. Regular eye exams can identify these risks and allow for early intervention.
Early stages of glaucoma often have no symptoms, but as the disease progresses, you may experience patchy blind spots in your side vision, tunnel vision, or halos around lights. If you notice any sudden vision changes, severe eye pain, or headaches, contact our office right away.
Some symptoms of glaucoma can overlap with other eye problems, such as cataracts or macular degeneration. Only a comprehensive eye exam can accurately diagnose glaucoma and distinguish it from these conditions, which is why early evaluation is key to protecting your vision.
Understanding MIGS
MIGS procedures use specialized microscopic tools to improve the eye's natural drainage system, offering a gentler approach to glaucoma surgery. They are a modern alternative to more invasive surgeries, offering hope for many patients.
Your eye constantly makes a clear fluid called aqueous humor that nourishes the eye. This fluid normally drains out through a network of tiny channels. When this drainage becomes blocked or less efficient, pressure builds up inside the eye, potentially damaging the optic nerve.
Traditional glaucoma surgeries like trabeculectomy require larger incisions, longer operating times, and extended recovery periods. MIGS, by contrast, uses micro-devices and microscopic incisions, minimizing tissue disruption and surgical risk, which often makes it a preferred option for mild to moderate cases.
MIGS is frequently performed at the same time as cataract surgery, providing a convenient, combined approach. Clinical studies show MIGS can lower eye pressure and reduce medication dependence in patients with mild to moderate glaucoma, without the higher risks of major surgery.
Patients typically report minimal discomfort, quick visual recovery, and a rapid return to normal activities. Because MIGS avoids many risks associated with traditional surgery, such as excessive scarring, patient satisfaction is often high, especially when their need for daily eye drops is reduced.
Types of MIGS Procedures
Several MIGS options are available, each targeting specific aspects of eye fluid drainage. Our ophthalmologists will recommend the procedure best suited to your unique anatomy and glaucoma severity.
The iStent Inject consists of two tiny titanium stents, among the smallest medical devices used in the human body, implanted into the eye's natural drainage channels. This quick procedure, often done during cataract surgery, helps improve fluid outflow and can reduce reliance on glaucoma medications.
The Hydrus Microstent is a flexible, crescent-shaped device that is slightly larger than an iStent and is designed to scaffold and open a wider section of the eye's natural drainage canal. It is particularly effective for mild to moderate open-angle glaucoma, with many patients experiencing sustained pressure reduction.
The Xen Gel Stent is a soft, flexible tube made of gelatin that creates a new drainage pathway from inside the eye to the space beneath the conjunctiva. It is often used for moderate to advanced glaucoma or when other MIGS options are insufficient, and recovery is typically fast.
This procedure uses a small electrocautery probe to precisely remove a strip of the eye's blocked natural drainage tissue. By clearing away the obstruction without an implant, it restores the eye's ability to drain fluid and is particularly effective for patients with primary open-angle glaucoma.
This technique uses a specially designed blade to make precise cuts in the drainage tissue, cleanly removing it without leaving behind debris that could cause scarring. It can be performed alone or combined with cataract surgery, offering flexibility and low complication rates.
ECP uses a laser probe through a small incision to treat the ciliary body, the tissue responsible for producing eye fluid. By reducing the production of aqueous humor, this technique lowers eye pressure and can be another effective option, especially when combined with cataract surgery.
Benefits and Risks of MIGS
MIGS offers significant advantages for glaucoma management, but like any medical procedure, it has potential risks. Understanding both sides helps you make confident, informed decisions about your treatment.
Many MIGS patients can reduce or even eliminate their need for daily glaucoma medications. This is often a highly valued benefit, as eye drops can be expensive, inconvenient, and cause side effects like redness or stinging.
Most MIGS patients return to normal activities like driving and working within a week, compared to several weeks or months for traditional surgeries. You can typically resume light exercise much sooner, though our ophthalmologists will provide specific guidelines based on your individual situation.
MIGS procedures have significantly lower rates of serious complications like infection, bleeding, or vision-threatening problems compared to traditional surgeries. The smaller incisions and gentler approach reduce tissue trauma and promote faster healing.
Because MIGS procedures are less invasive and do not create extensive tissue changes, they preserve your options for future treatments. If needed, additional MIGS procedures or even traditional surgeries can still be performed later.
While generally safe, potential complications can include temporary inflammation, a short-term spike in eye pressure, or minor bleeding. More serious risks like infection or device displacement are rare. Our ophthalmologists will discuss your individual risk profile before the procedure.
Who is a Candidate for MIGS?
MIGS is particularly suited for patients with mild to moderate open-angle glaucoma who are not controlled with medications alone or wish to reduce their medication burden. Candidacy depends on your type of glaucoma, overall eye health, and other individual factors.
Good candidates typically have primary open-angle glaucoma with mild to moderate damage and eye pressure that isn't well-controlled with medications alone. Patients who have difficulty with eye drop compliance or experience significant side effects from medications often make excellent candidates.
Our ophthalmologists will review your complete medical history and perform a detailed eye exam to evaluate your optic nerve damage, visual field loss, and the anatomy of your eye's drainage system. This comprehensive assessment helps determine which MIGS procedure would be most effective for your specific situation.
Your commitment to follow-up care is important for long-term success. Patients who want to maintain an active lifestyle often appreciate the quicker recovery that MIGS offers compared to more invasive surgeries.
MIGS might not be recommended if you have severe or advanced glaucoma damage, certain types of secondary glaucoma, or significant scarring from previous eye surgeries. These cases may require more aggressive traditional surgical approaches to achieve adequate pressure reduction.
It is important to have realistic expectations. MIGS aims to lower eye pressure and reduce medication use, but it is not a cure for glaucoma. Open communication with our ophthalmologists about your goals and concerns is a key part of successful management.
What to Expect During and After MIGS
Understanding the MIGS process from start to finish can help reduce anxiety and ensure the best possible outcome. Most patients find the experience more comfortable and straightforward than they expected.
Our ophthalmologists will perform comprehensive testing and give you detailed instructions about medications, eating, and what to bring on surgery day. You must arrange for reliable transportation, as you will not be able to drive immediately after the procedure.
MIGS is usually performed in an outpatient setting with local anesthesia and possibly mild sedation to help you relax. The actual procedure is quick, typically taking 15 to 45 minutes depending on the technique and whether it is combined with cataract surgery.
After MIGS, you may experience mild discomfort, blurred vision, or sensitivity to light for a few days. You will use prescribed antibiotic and anti-inflammatory eye drops to prevent infection and reduce inflammation. It is important to attend all follow-up visits to monitor healing.
To ensure a smooth recovery, please follow these guidelines:
- Use all prescribed eye drops exactly as directed.
- Avoid rubbing, touching, or pressing on your eye.
- Wear a protective eye shield at night if recommended.
- Refrain from swimming, using hot tubs, or strenuous activities until cleared by your doctor.
- Attend all scheduled follow-up appointments.
- Contact your provider immediately if you experience severe pain, worsening vision, or signs of infection.
Even after a successful MIGS procedure, glaucoma requires lifelong monitoring. Regular visits allow our ophthalmologists to check your eye pressure and optic nerve health, ensuring your vision remains protected for years to come.
Frequently Asked Questions
Here are answers to some common questions patients have about MIGS. We encourage you to discuss any other questions or concerns with our ophthalmologists.
MIGS procedures are designed to be comfortable. Local anesthesia completely numbs your eye, so you may feel slight pressure but no sharp pain during surgery. Afterward, most patients experience only mild discomfort that can be managed with over-the-counter pain relievers.
Most patients notice significant improvement within the first week and can return to normal activities within a few days. Full healing typically occurs within 4 to 6 weeks, though you should avoid heavy lifting and strenuous exercise initially as advised by your surgeon.
No, MIGS cannot cure glaucoma, but it can effectively manage the condition by lowering eye pressure and slowing its progression. Glaucoma is a lifelong condition that requires ongoing monitoring and care, even after successful surgery.
Yes, alternatives include prescription eye drops, oral medications, laser treatments like selective laser trabeculoplasty (SLT), and traditional surgeries such as trabeculectomy or tube shunts. Our ophthalmologists can discuss which option is best for your specific type and stage of glaucoma.
Studies show MIGS often provides more consistent and stable eye pressure control than eye drops alone, especially for patients who struggle with medication compliance or side effects. For many, MIGS can be a more reliable long-term solution.
Yes, in many cases. The minimally invasive nature of MIGS preserves the eye's structures, allowing for additional treatments, including another MIGS procedure or traditional surgery, if eye pressure rises again over time.
MIGS is considered very safe for older adults and is commonly performed in patients over 65. The gentler approach and faster recovery make it particularly well-suited for seniors who may not tolerate more extensive surgeries as well.
Absolutely. Regular eye exams remain essential after MIGS to monitor your glaucoma and ensure the treatment continues working effectively. These visits help catch any changes early and adjust your treatment plan if needed to protect your vision.
Maintaining a healthy lifestyle with regular exercise, a balanced diet rich in leafy greens, and protecting your eyes from injury all support good outcomes. Managing other health conditions like diabetes and high blood pressure is also very important for your overall eye health.
No, MIGS does not negatively impact cataract surgery outcomes. In fact, combining both procedures often provides excellent results for both vision clarity and glaucoma control, with the convenience of a single surgery and recovery period.
Most patients can resume driving within a few days to a week after MIGS, once their vision has cleared and they feel comfortable and safe to do so. Our ophthalmologists will evaluate your vision at follow-up visits and let you know when it is safe.
Most insurance plans, including Medicare, cover medically necessary MIGS procedures. However, coverage details can vary by provider and the specific procedure, so it is always wise to check with your insurance company beforehand to avoid unexpected costs.
If MIGS does not provide sufficient pressure reduction, additional treatments can be added. These might include resuming eye drops, undergoing laser therapy, performing another MIGS procedure, or moving to traditional surgery. Our ophthalmologists will work with you to find the most effective approach.
Taking the Next Step
If you have glaucoma or are at risk, discussing MIGS with our ophthalmologists at ReFocus Eye Health Hatboro can help you understand all your treatment options. Early intervention and appropriate treatment can make a significant difference in preserving your vision and maintaining your quality of life.
Contact Us
Tuesday: 8AM-4PM
Wednesday: 8AM-4PM
Thursday: 8AM-4PM
Friday: 8AM-4PM
Saturday: Closed
Sunday: Closed
